2013 annual financial data
XTL Biopharmaceuticals 2013 Operating margin
Direct answer
Operating margin was -122.16%.
Operating income was -2,894,000 USD and net income was -2,476,000 USD.
Operating cash flow was -2,499,000 USD.
Get free XTL Biopharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,369,000 USD
- Operating income
- -2,894,000 USD
- Net income
- -2,476,000 USD
- Operating cash flow
- -2,499,000 USD